Etanercept for Toxic Epidermal Necrolysis

Abstract

Get full access to this article

View all access options for this article.

References

1. Roujeau

Kelly

Naldi

. Medication use and the risk of Stevens—Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600–7.

2. Chave

Mortimer

Sladden

Hall

Hutchinson

. Toxic epidermal necrolysis: Current evidence, practical management and future directions. Br J Dermatol 2005;153:241–53.

3. Naranjo

Busto

Sellers

. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–45.

4. Fischer

Fiedler

Marsch

Wohlrab

. Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis. Br J Dermatol 2002;146:707–9.

5. Hunger

Hunziker

Buettiker

Braathen

Yawalkar

. Rapid resolution of toxic epidermal necrolysis with anti—TNF-alpha treatment. J Allergy Clin Immunol 2005;116:923–4.